Page 275

61. Medana IM, Gallimore A, Oxenius A, Martinic MMA, Wekerle H, Neumann H. 2000. MHC class I-restricted killing of neurons by virus specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perform pathway. Eur.J.Immunol.; 30: 3623-3633.

62. MeinL E, Hoch RM, Dornmair K, et al. 1997. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am J Pathol.; 150: 445-53.

63. Merrill EG, Wall PD. 1978. Selective inhibition of distant afferent input to lamina 4 and 5 cells in cat dorsal spinal cord. J Physiol (Lond).; 278: 51P.

64. Mogilner A, Grossman JA, Ribary U, et al. 1993. Somatosensory cortical plasticity in adult humans revealed by magnetoencephalography. Proc Natl Acad Sci U S A.; 90: 3593-7.

65. Moll C, Mourre C, Lazdunski M, Ulrich J. 1991. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res.; 556: 311-6.

66. Narayanan S, Fu L, Pioro E, et al. 1997. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol.; 41: 385-91.

67. Neumann H, Wekerle H. 1998. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol.; 57: 1-9.

68. Nudo RJ. 1999. Recovery after damage to motor cortical areas. Curr Opin Neurobiol.; 9: 740-7.

69. Olivares-Villagomez D, Wang Y, Lafaille JJ. 1998. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med.; 188: 1883-94.

70. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature.; 346: 183-7.

71. Paty DW, Moore GR. Magnetic Resonance Imaging Changes as Living Pathology in Multiple Sclerosis. Paty DW, Ebers GC, eds. Multiple Sclerosis. Philadelphia, PA: F.A. Davis Company; 1998: 328-369.

72. Pette M, Fujita K, Kitze B, et al. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology.; 40: 1770-6.

73. Pitt D, Werner P, Raine CS. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med.; 6: 67-70.

74. Pons TP, Garraghty PE, Ommaya AK, Kaas JH, Taub E, Mishkin M. 1991. Massive cortical reorganization after sensory deafferentation in adult macaques [see comments]. Science.; 252: 1857-60.

75. Prat A, Pelletier D, Duquette P, Arnold DL, Antel JP. 2000. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume. Ann Neurol.; 47: 234-7.

76. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J. 1998. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest.; 102: 1045-50.

77. Ramachandran VS, Rogers-Ramachandran D. 2000. Phantom limbs and neural plasticity. Arch Neurol.; 57: 317-20.

78. Ramachandran VS, Rogers-Ramachandran D, Stewart M. 1992. Perceptual correlates of massive cortical reorganization. Science.; 258: 1159-60.

79. Ramachandran VS, Stewart M, Rogers-Ramachandran DC. 1992. Perceptual correlates of massive cortical reorganization. Neuroreport.; 3: 583-6.

80. Ransom BR, Waxman SG, Davis PK. 1990. Anoxic injury of CNS white matter: protective effect of ketamine. Neurology.; 40: 1399-403.

81. Rioult-Pedotti MS, Friedman D, Hess G, Donoghue JP. 1998. Strengthening of horizontal cortical connections following skill learning. Nat Neurosci.; 1: 230-4.

82. Rodi DJ, Makowski L. 1999. Phage-display technology—finding a needle in a vast molecular haystack. Curr Opin Biotechnol; 10: 87-93.

83. Rubin LL, Staddon JM. 1999. The cell biology of the blood-brain barrier. Annu Rev Neurosci.; 22: 11-28.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement